Interventional Oncology Market to experience hike in growth by 2025

Global Interventional Oncology Market: Snapshot

The increasing demand for minimally invasive (MI) procedures is driving the growth of the global market for interventional oncology. The growing awareness about the benefits of MI surgeries, such as reduced risk of infection, minimal complications, shorter hospital stay, lesser pain, and a faster recovery time when compared to the conventional open surgeries, are encouraging patients and surgeons to opt for MI surgeries, resulting in the high growth of this market. The global interventional oncology market will continue to be driven by these factors over the coming years.

The increasing incorporation of image-guided solutions in interventional oncology procedures, thanks to the improvement these solutions provide in the diagnosis and treatment of cancer-related issues, is also expected to supplement the growth prospects of this market in the near future.

Request Sample Copy of the Report @

The presence of a number of local and international vendors characterizes the business landscape of the worldwide market for interventional oncology, which is highly competitive and diversified. Technological advancements and constant introduction of new products are likely to intensify the competitive environment in the market. The leading players are focusing aggressively on expanding their product portfolios.

Global Interventional Oncology Market: Overview

Interventional oncology, a subspecialty of interventional radiology, finds application in the diagnosis and treatment of cancer and cancer-related problems. It is an image-guided, minimally-invasive technique conducted by trained experts. Most procedures are either outpatient or require an overnight stay in the hospital. Recovery time is also minimal. Some of the popular procedures used are intra-arterial therapies, ablative therapies, pain palliation, and neoadjuvant (pre-operative) procedures.

Request TOC of the Report @

A report by TMR research studies the global market for oncology intervention in details by factoring in current and historical data. It presents a qualitative analysis of the growth drivers and restraints and also projects it growth trajectory in the future.

Global Interventional Oncology Market: Key Trends

Fanning growth in the global interventional oncology market is the increasing instances of liver, lung, stomach, colorectal, and breast cancer worldwide. This has upped demand for minimally invasive procedures to treat or eliminate cancerous cells. On account of their targeted nature that cause little damage to adjacent tissues and organs, cause little complications, and result in a shorter recovery time, minimally invasive techniques in interventional oncology has stolen a march over alternative cancer treatments such as conventional surgeries, systematic chemotherapy, and radiation therapy, and systematic chemotherapy.

Read Comprehensive Overview of Report@

Additionally, the rising combination of image-guided solutions with interventional oncology procedures will also likely stoke the global market for interventional oncology in the next couple of years.

Global Interventional Oncology Market: Market Potential

The global market for interventional oncology is primed for healthy growth in the foreseeable future. A growing thrust on pairing up interventional oncology drugs with device-based interventional oncology procedures could make the procedure mainstream soon. This would likely provide a major fillip to the market.

Depending upon procedure and analysis, the global market for interventional oncology can be segmented into ablation and embolization. Of the two, the interventional oncology embolization segment holds a leading share in the market and would continue doing so in the near future. This is because of the rising need for minimally invasive procedures in the treatment of cancer, uptake of embolization procedures by hospitals and ASCs, and direct selling of embolization products, namely DC Bead, Bead Block, and DC Bead M1.

Global Interventional Oncology Market: Regional Outlook

Geographically, the key segments of the market are the Americas, Asia Pacific, and the Europe, Middle East, and Africa. Among them, the Americas hold a leading position and will continue doing so in the upcoming years as well on account of the rising instances of cancer, increasing application of minimally invasive procedures, technological progress such as robotic navigation systems, and effective medical  reimbursement policies. Increasing support from the government and other organizations for research and developmental activities is also expected to bode well for the market in the region.

Global Smart Plug Market: Competitive Analysis

The global market for interventional oncology is highly competitive and diversified because of the presence of numerous regional and international vendors worldwide. The market is highly dynamic on account of rapid technological advancements and unveiling of new products from time to time. All of these are also serving to intensify the competition in the market. Many savvy vendors are leveraging advanced technologies to improve their product portfolio, bring out innovative products, and enhance patient satisfaction. This has helped them outsmart new entrants. Some of the key players profiled in the report are Boston Scientific, Medtronic, BTG, TERUMO, and Merit Medical.

Minimally Invasive Procedures Driving Demand for Interventional Oncology

San Francisco, California, February 21, 2018 – On the back of growing adoption of minimally invasive (MI) procedures, the market for interventional oncology is poised for a prosperous future, according to a recent business intelligence study by TMR Research. The report, titled “Interventional Oncology Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” has detected that interventional oncology involves MI procedures in order to treat inoperable patients. The report, compiled by a group of professional market research analysts, aspires to serve as a decision-making document for the stockholders of this market such as healthcare providers, hospitals, diagnostic centers, research and consulting firms, venture capitalists, and regulatory bodies. The report is a summation of in-depth analysis all factors that may define the demand in the market for interventional oncology during the forecast period of 2017 to 2025, divides it into smaller segments of various aspects, and explores the competitive landscape in order to represent the possibilities of entrance of new players.

Some of the key factors expected to drive the demand in the global interventional oncology market are: growing cancer population, increased research and development activities, advancements in the technology, and growing demand for minimally invasive procedures. The ability of MI procedures to act against cancerous cells in a much more proficient way than conventional surgeries, systematic chemotherapy, and radiation therapy is providing a major boost to the market. On the other hand, risks associated with the interventional oncology procedures, limited skilled practitioners, presence of alternatives, and high cost of the procedures are obstructing the market from attaining its true potential. That being said, the vendors operating in this market are expected to gain new opportunities from growing integration of image-guided solutions with interventional oncology procedures, growing focus on the adoption of MWA, increasing inorganic growth strategies by vendors, growing adoption of HIFU and SIRT, and intense competitive between the players.

Based on procedure, the global interventional oncology market can be segmented into ablation, radiation therapy, and embolization. Currently, the latter provides for the majority of the demand in this market and is expected to remain dominant throughout the forecast period. Increasing need for MI procedures for the treatment of cancer and growing adoptability among hospital organizations are a few factors driving the demand for the segment of embolization.

Geographically, North America is the region that is providing for the major chunk of demand in the global interventional oncology market and is expected to remain so throughout the forecast period of this report. This prosperity of the North America interventional oncology market is a result of growing adoption of MI procedures, prevalence of cancer, advancements in technology by the vendors operating in this market including robotic navigation systems, and the improved reimbursement by Medicare. The government in the developed countries of the U.S. and Canada are also favoring the research and development activities and driving this regional market.

Medtronic, Boston Scientific, BTG, TERUMO, and Merit Medical are a few key companies currently ahead of the curve in the global interventional oncology market. In addition to that, Smith & Nephew, ALPINION MEDICAL SYSTEMS, Cook Medical, Accuray, AngioDynamics, C2 Therapeutics, BOVIE MEDICAL, Brainlab, BSD Medical, Mermaid Medical, AtriCure, Baylis Medical, C. R. Bard, CardioFocus, Eckert and Ziegler BEBIG, Profound Medical, Elekta, EDAP TMS, Galil Medical, HealthTronics, MedWaves, INSIGHTEC, Microsulis Medical, NeuWave Medical, Monteris Medical, Perseon, Sirtex, Varian Medical, and SonaCare Medical are some of the other notable players. For each of these players that have been profiled in the report, analysts have showcased their business overview.

Get Sample Copy of this Report